Expression of EGFR-mutant proteins and genomic evolution in EGFR-mutant transformed small cell lung cancer
Shiling Zhang(China National Petroleum Corporation (China)), Jin‐Ji Yang(Guangdong General Hospital)
Cited by 9
Related Papers
Lysosome Targeting Chimaeras for Glut1-Facilitated Targeted Protein Degradation
|Journal of the American Chemical Society|2024|47
Clinical outcomes of advanced non-small-cell lung cancer patients with <i>EGFR</i> mutation, <i>ALK</i> rearrangement and <i>EGFR</i>/<i>ALK</i> co-alterations
|Oncotarget|2016|39
Expert consensus on treatment for stage III non‐small cell lung cancer
|Medicine Advances|2023|18